Christoper Hufnagel Form 3 WOLVERINE WORLD WIDE / CHRISTOPER HUFNAGEL ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HUFNAGEL CHRISTOPER

(Last)

(First)

(Middle)

C/O 9341 COURTLAND DRIVE NE

(Street)

ROCKFORD

49351

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/29/2020

3. Issuer Name and Ticker or Trading Symbol
WOLVERINE WORLD WIDE INC /DE/ [ WWW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
President, Merrell

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	64,199⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)⁽²⁾	02/09/2012⁽³⁾	02/08/2021	Common Stock	12,300	18.25	D
Stock Options (Right to Buy)⁽²⁾	02/08/2013⁽⁴⁾	02/07/2022	Common Stock	18,000	19.92	D
Stock Options (Right to Buy)⁽²⁾	02/06/2014⁽⁵⁾	02/05/2023	Common Stock	19,420	21.48	D
Stock Options (Right to Buy)	02/11/2015⁽⁶⁾	02/10/2024	Common Stock	17,022	27.13	D
Stock Options (Right to Buy)	02/11/2016⁽⁷⁾	02/10/2025	Common Stock	16,789	28	D
Stock Options (Right to Buy)	02/10/2017⁽⁸⁾	02/09/2026	Common Stock	32,294	16.51	D
Restricted Stock Units	⁽⁹⁾	⁽⁹⁾	Common Stock	2,246	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹¹⁾	⁽¹¹⁾	Common Stock	3,203	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹²⁾	⁽¹²⁾	Common Stock	3,908	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹³⁾	⁽¹³⁾	Common Stock	1,500	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹⁴⁾	⁽¹⁴⁾	Common Stock	1,000	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹⁵⁾	⁽¹⁵⁾	Common Stock	5,176	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹⁶⁾	⁽¹⁶⁾	Common Stock	3,855	0.00⁽¹⁰⁾	D
Restricted Stock Units	⁽¹⁷⁾	⁽¹⁷⁾	Common Stock	5,783	0.00⁽¹⁰⁾	D

Explanation of Responses:

1. The number of shares reported includes 7,297 time-vested restricted shares of Common Stock granted to the Reporting Person on various dates from December 2015 to February 2016, under both the Company's Stock Incentive Plan of 2013 and Stock Incentive Plan of 2016.

2. The number of shares and exercise price have been adjusted to reflect the Company's November 1, 2013 two-for-one stock split.

3. This option became exercisable as to 4,100 shares on February 9, 2012, as to 4,100 shares on February 9, 2013, and as to 4,100 shares on February 9, 2014.

4. This option became exercisable as to 6,000 shares on February 8, 2013, as to 6,000 shares on February 8, 2014, and as to 6,000 shares on February 8, 2015.

5. This option became exercisable as to 6,474 shares on February 6, 2014, as to 6,473 shares on February 6, 2015, and as to 6,473 shares on February 6, 2016.

6. This option became exercisable as to 5,674 shares on February 11, 2015, as to 5,674 shares on February 11, 2016, and as to 5,674 shares on February 11, 2017.

7. This option became exercisable as to 5,597 shares on February 11, 2016, as to 5,596 shares on February 11, 2017, and as to 5,596 shares on February 11, 2018.

8. This option became exercisable as to 10,765 shares on February 10, 2017, as to 10,764 shares on February 10, 2018, and as to 10,765 shares on February 10, 2019.

9. On February 8, 2017, the Reporting Person was granted 7,486 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 20%, 20%, 30% and 30% on each of the first, second, third and fourth year anniversaries of the grant date, respectively. The restricted stock units have no expiration date.

10. Restricted stock units convert into shares of Common Stock on a one-for-one basis.

11. On February 7, 2018, the Reporting Person was granted 5,338 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 20%, 20%, 30% and 30% on each of the first, second, third and fourth year anniversaries of the grant date, respectively. The restricted stock units have no expiration date.

12. On February 6, 2019, the Reporting Person was granted 4,884 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 20%, 20%, 30% and 30% on each of the first, second, third and fourth year anniversaries of the grant date, respectively. The restricted stock units have no expiration date.

13. On October 28, 2019, the Reporting Person was granted 1,500 restricted stock units, vesting 50% on each of the first and second year anniversaries of the grant date, subject to the Reporting Person's continued employment. The restricted stock units have no expiration date.

14. On January 27, 2020, the Reporting Person was granted 1,000 restricted stock units, vesting 100% on the first anniversary of the grant date, subject to the Reporting Person's continued employment. The restricted stock units have no expiration date.

15. On February 5, 2020, the Reporting Person was granted 5,176 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: 20%, 20%, 30% and 30% on each of the first, second, third and fourth year anniversaries of the grant date, respectively. The restricted stock units have no expiration date.

16. On April 17, 2020, the Reporting Person was granted 3,855 restricted stock units, vesting 100% on the first anniversary of the grant date, subject to the Reporting Person's continued employment. The restricted stock units have no expiration date.

17. On April 17, 2020, the Reporting Person was granted 5,783 restricted stock units, vesting 100% on December 23, 2020, subject to the Reporting Person's continued employment. The restricted stock units have no expiration date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ David Latchana, by Power of Attorney	05/01/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Christoper Hufnagel Form 3WOLVERINE WORLD WIDE / CHRISTOPER HUFNAGEL ownership change